Cargando…

Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units

BACKGROUND: Following one to five years of antibiotic mass drug administration (MDA) for the elimination of trachoma as a public health problem, programmes must conduct impact surveys to inform decisions on whether MDA is still needed. These decisions are currently based on the prevalence of trachom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burr, Sarah E., Hart, John, Samikwa, Lyson, Chaima, David, Cooley, Gretchen, Martin, Diana, Masika, Michael, Solomon, Anthony W., Bailey, Robin L., Kalua, Khumbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816554/ https://www.ncbi.nlm.nih.gov/pubmed/31658258 http://dx.doi.org/10.1371/journal.pntd.0007749

Ejemplares similares

Trachoma, Anti-Pgp3 Serology, and Ocular Chlamydia trachomatis Infection in Papua New Guinea
por: Macleod, Colin K, et al.
Publicado: (2020)

Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati
por: Cama, Anaseini, et al.
Publicado: (2017)

Baseline Trachoma Mapping in Malawi with the Global Trachoma Mapping Project (GTMP)
por: Kalua, Khumbo, et al.
Publicado: (2015)

The effect of Mass Drug Administration for trachoma on antibodies to Chlamydia trachomatis pgp3 in children
por: West, Sheila K., et al.
Publicado: (2020)

Ocular Chlamydia trachomatis infection, anti-Pgp3 antibodies and conjunctival scarring in Vanuatu and Tarawa, Kiribati before antibiotic treatment for trachoma
por: Butcher, Robert, et al.
Publicado: (2020)

Comparison of Platforms for Testing Antibody Responses against the Chlamydia trachomatis Antigen Pgp3
por: Gwyn, Sarah, et al.
Publicado: (2017)

Prevalence of nasopharyngeal Streptococcus pneumoniae carriage and resistance to macrolides in the setting of azithromycin mass drug administration: analysis from a cluster-randomised controlled trial in Malawi, 2015–17
por: Hart, John D, et al.
Publicado: (2022)

Longitudinal change in the serology of antibodies to Chlamydia trachomatis pgp3 in children residing in a trachoma area
por: West, Sheila K., et al.
Publicado: (2018)

The Performance of Immunoassays to Measure Antibodies to the Chlamydia trachomatis Antigen Pgp3 in Different Epidemiological Settings for Trachoma
por: Gwyn, Sarah, et al.
Publicado: (2021)

Completion of Baseline Trachoma Mapping in Malawi: Results of Eight Population-Based Prevalence Surveys Conducted with the Global Trachoma Mapping Project
por: Kalua, Khumbo, et al.
Publicado: (2016)

Trachoma: Protective and Pathogenic Ocular Immune Responses to Chlamydia trachomatis
por: Hu, Victor H., et al.
Publicado: (2013)

Latent class modeling to compare testing platforms for detection of antibodies against the Chlamydia trachomatis antigen Pgp3
por: Wiegand, Ryan E., et al.
Publicado: (2018)

Prevalence and Risk Factors for Trachoma in Central and Southern Malawi
por: Kalua, Khumbo, et al.
Publicado: (2010)

Low Prevalence of Ocular Chlamydia trachomatis Infection and Active Trachoma in the Western Division of Fiji
por: Macleod, Colin K., et al.
Publicado: (2016)

Chlamydia trachomatis Pgp3 Antibody Population Seroprevalence before and during an Era of Widespread Opportunistic Chlamydia Screening in England (1994-2012)
por: Woodhall, Sarah C., et al.
Publicado: (2017)

Risk Factors for Active Trachoma and Ocular Chlamydia trachomatis Infection in Treatment-Naïve Trachoma-Hyperendemic Communities of the Bijagós Archipelago, Guinea Bissau
por: Last, Anna R., et al.
Publicado: (2014)

Natural Products for the Treatment of Trachoma and Chlamydia trachomatis
por: Potroz, Michael G., et al.
Publicado: (2015)

Risk of seroconversion and seroreversion of antibodies to Chlamydia trachomatis pgp3 in a longitudinal cohort of children in a low trachoma prevalence district in Tanzania
por: Chen, Xinyi, et al.
Publicado: (2022)

Viability PCR shows that non-ocular surfaces could contribute to transmission of Chlamydia trachomatis infection in trachoma
por: Versteeg, Bart, et al.
Publicado: (2020)

The World Health Organization Recommendations for Trachoma Surveillance, Experience in Nepal and Added Benefit of Testing for Antibodies to Chlamydia trachomatis pgp3 Protein: NESTS Study
por: Zambrano, Andrea I., et al.
Publicado: (2016)

Active Trachoma and Ocular Chlamydia trachomatis Infection in Two Gambian Regions: On Course for Elimination by 2020?
por: Harding-Esch, Emma M., et al.
Publicado: (2009)

Genomics of Ocular Chlamydia trachomatis After 5 Years of SAFE Interventions for Trachoma in Amhara, Ethiopia
por: Pickering, Harry, et al.
Publicado: (2020)

Spatial clustering of high load ocular Chlamydia trachomatis infection in trachoma: a cross-sectional population-based study
por: Last, Anna, et al.
Publicado: (2017)

Detecting extra-ocular Chlamydia trachomatis in a trachoma-endemic community in Ethiopia: Identifying potential routes of transmission
por: Last, Anna, et al.
Publicado: (2020)

Effects of Biannual Azithromycin Mass Drug Administration on Malaria in Malawian Children: A Cluster-Randomized Trial
por: Hart, John D., et al.
Publicado: (2020)

The Easiest Children to Reach Are Most Likely to Be Infected with Ocular Chlamydia trachomatis in Trachoma Endemic Areas of Niger
por: Amza, Abdou, et al.
Publicado: (2013)

The Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic Treatment
por: Ramadhani, Athumani M., et al.
Publicado: (2016)

Population-based analysis of ocular Chlamydia trachomatis in trachoma-endemic West African communities identifies genomic markers of disease severity
por: Last, A. R., et al.
Publicado: (2018)

Costs of Testing for Ocular Chlamydia trachomatis Infection Compared to Mass Drug Administration for Trachoma in The Gambia: Application of Results from the PRET Study
por: Harding-Esch, Emma, et al.
Publicado: (2015)

Validation of immunoassays for the Chlamydia trachomatis antigen Pgp3 using a chimeric monoclonal antibody
por: Goodhew, Brook, et al.
Publicado: (2023)

Population-Based Prevalence of Ocular Chlamydia trachomatis Infection among Infants in the Trachoma Endemic Amhara Region, Ethiopia
por: Nash, Scott D., et al.
Publicado: (2022)

Prevalence of Ocular Chlamydia trachomatis Infection in Amhara Region, Ethiopia, after 8 Years of Trachoma Control Interventions
por: Nash, Scott D., et al.
Publicado: (2023)

Conjunctival transcriptome profiling of Solomon Islanders with active trachoma in the absence of Chlamydia trachomatis infection
por: Vasileva, Hristina, et al.
Publicado: (2018)

183. chlamydia Trachomatis Seroprevalence with a pgp3 Serologic Assay and Association with Pelvic Inflammatory Disease Among Women, United States, 2013–2016
por: Anyalechi, Gloria E, et al.
Publicado: (2020)

Plasmid Negative Regulation of CPAF Expression Is Pgp4 Independent and Restricted to Invasive Chlamydia trachomatis Biovars
por: Patton, Michael John, et al.
Publicado: (2018)

Concordance of ompA types in children re-infected with ocular Chlamydia trachomatis following mass azithromycin treatment for trachoma
por: Mosenia, Arman, et al.
Publicado: (2022)

Serological and PCR-based markers of ocular Chlamydia trachomatis transmission in northern Ghana after elimination of trachoma as a public health problem
por: Senyonjo, Laura G., et al.
Publicado: (2018)

Chlamydia trachomatis ompA Variants in Trachoma: What Do They Tell Us?
por: Andreasen, Aura A., et al.
Publicado: (2008)

Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
por: Hong, Kevin Cyrus, et al.
Publicado: (2009)

Estimating Household and Community Transmission of Ocular Chlamydia trachomatis
por: Blake, Isobel M., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_6f7dc0r9c5iek72ffrsiaiubdu